Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation R Childs, A Chernoff, N Contentin, E Bahceci, D Schrump, S Leitman, ... New England Journal of Medicine 343 (11), 750-758, 2000 | 1340 | 2000 |
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse SJ Lee, JP Klein, AJ Barrett, O Ringden, JH Antin, JY Cahn, MH Carabasi, ... Blood, The Journal of the American Society of Hematology 100 (2), 406-414, 2002 | 678 | 2002 |
Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses R Childs, E Clave, N Contentin, D Jayasekera, N Hensel, S Leitman, ... Blood, The Journal of the American Society of Hematology 94 (9), 3234-3241, 1999 | 676 | 1999 |
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study CRY Cruz, KP Micklethwaite, B Savoldo, CA Ramos, S Lam, S Ku, ... Blood, The Journal of the American Society of Hematology 122 (17), 2965-2973, 2013 | 621 | 2013 |
Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation JR Hobbs, AJ Barrett, D Chambers, DCO James, K Hugh-Jones, N Byrom, ... The Lancet 318 (8249), 709-712, 1981 | 602 | 1981 |
Graft-versus-leukemia reactions in allogeneic chimeras HJ Kolb, C Schmid, AJ Barrett, DJ Schendel Blood 103 (3), 767-776, 2004 | 554 | 2004 |
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis P Teira, M Battiwalla, M Ramanathan, AJ Barrett, KW Ahn, M Chen, ... Blood, The Journal of the American Society of Hematology 127 (20), 2427-2438, 2016 | 549 | 2016 |
High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT K Rezvani, S Mielke, M Ahmadzadeh, Y Kilical, BN Savani, J Zeilah, ... Blood 108 (4), 1291-1297, 2006 | 501 | 2006 |
Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies K Rezvani, ASM Yong, S Mielke, BN Savani, L Musse, J Superata, ... Blood, The Journal of the American Society of Hematology 111 (1), 236-242, 2008 | 456 | 2008 |
Hepatitis-associated aplastic anemia KE Brown, J Tisdale, AJ Barrett, CE Dunbar, NS Young New England Journal of Medicine 336 (15), 1059-1064, 1997 | 433 | 1997 |
Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells J Molldrem, S Dermime, K Parker, YZ Jiang, D Mavroudis, N Hensel, ... | 427 | 1996 |
HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome Y Saunthararajah, R Nakamura, JM Nam, J Robyn, F Loberiza, ... Blood, The Journal of the American Society of Hematology 100 (5), 1570-1574, 2002 | 386 | 2002 |
Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome M Stetler-Stevenson, DC Arthur, N Jabbour, XY Xie, J Molldrem, ... Blood, The Journal of the American Society of Hematology 98 (4), 979-987, 2001 | 385 | 2001 |
Antithymocyte globulin for patients with myelodysplastic syndrome JJ Molldrem, M Caples, D Mavroudis, M Plante, NS Young, AJ Barrett British journal of haematology 99 (3), 699-705, 1997 | 372 | 1997 |
Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia RL Powles, HEM Kay, HM Clink, A Barrett, MH Depledge, J Sloane, ... The Lancet 321 (8325), 612-615, 1983 | 351 | 1983 |
Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia EE Solomou, K Rezvani, S Mielke, D Malide, K Keyvanfar, V Visconte, ... Blood, The Journal of the American Society of Hematology 110 (5), 1603-1606, 2007 | 338 | 2007 |
Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation JE Levine, T Braun, SL Penza, P Beatty, K Cornetta, R Martino, ... Journal of Clinical Oncology 20 (2), 405-412, 2002 | 336 | 2002 |
Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell–depleted hematopoietic allograft ME Horwitz, AJ Barrett, MR Brown, CS Carter, R Childs, JI Gallin, ... New England Journal of Medicine 344 (12), 881-888, 2001 | 320 | 2001 |
The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP) MJ Peckham, A Barrett, KH Liew, A Horwich, B Robinson, HJ Dobbs, ... British Journal of Cancer 47 (5), 613-619, 1983 | 320 | 1983 |
Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Societe Francaise de Greffe de Moelle et Therapie Cellulaire (SFGM-TC), Dana Farber Cancer … JY Cahn, JP Klein, SJ Lee, N Milpied, D Blaise, JH Antin, V Leblond, ... Blood 106 (4), 1495-1500, 2005 | 310 | 2005 |